Closed System Transfer Devices Market Size To Hit US$ 1,620.6 Million By 2027

The global closed system transfer device market size is expected to hit around USD 1,620.6 million by 2027 and progressing a CAGR of 20.6% over the forecast period 2020 to 2027.

Closed System Transfer Device Market Size 2016 to 2027

The on closed system transfer device Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/1180

Report Scope of the Clinical Trials Market

Report Highlights	Details
Market Size	USD 1620.6 Million by 2027
Growth Rate	CAGR of 20.6% from 2021 to 2027
Largest Market	North America
Fastest Growing Market	Asia Pacific
Base Year	2021
Forecast Period	2021 to 2027
Segments Covered	Type, Component, End User, Closing Mechanism, Region

A recent report provides crucial insights along with application based and forecast information in the Global Closed system transfer device Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Closed system transfer device market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Closed system transfer device market are included as given below:

Closed system transfer device Market Key Players

Baxter International Inc.
Becton, Dickinson, and Company
CodanMedizinischeGeräte GmbH & Co Kg
ICU Medical, Inc.
Yukon Medical
Braun Melsungen
Equashield
Teva Pharmaceutical Industries Ltd.
Victus, Inc.
Corvida Medical

Market Segments

By Type

Needleless Systems
Membrane-to-Membrane Systems

By Closing Mechanism

Color-To-Color Alignment Systems
Push-To-Turn Systems
Click-To-Lock Systems
Luer-Lock Systems

By Component

Syringe Safety Devices
Vial Access Devices
Accessories
Bag/Line Access Devices

By End User

Clinics & Oncology Centers
Hospitals
Others

By Geography

North America

U.S.
Canada

Europe

Germany
France
United Kingdom
Rest of Europe

Asia Pacific

China
Japan
India
Southeast Asia
Rest of Asia Pacific

Latin America

Brazil
Rest of Latin America

Middle East & Africa (MEA)

GCC
North Africa
South Africa
Rest of Middle East & Africa

Report Objectives

To define, describe, and forecast the global closed system transfer device market based on product, and region
To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the closed system transfer device market

Table of Content

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Regenerative Medicine Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Regenerative Medicine Market

5.1. Covid-19: Regenerative Medicine Industry Impact
5.2. Regenerative Medicine Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Regenerative Medicine Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Regenerative Medicine Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Regenerative Medicine Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Increasing prevalence of cancer
6.1.1.2. Growing need for regulatory compliance for safe handling of harmful drugs
6.1.2. Market Restraints
6.1.2.1. High cost systems
6.1.3. Market Opportunities
6.1.3.1. Rising adoption of closed system transfer devices for transferring hazardous drugs
6.1.3.2. Increasing use of CSTDs in emerging markets

Chapter 7. Global Regenerative Medicine Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Regenerative Medicine Market Revenue by Market Players (2016 -2019)
7.1.1.2. Regenerative Medicine Market Revenue Market Share by Market Players (2016 -2019)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Regenerative Medicine Market, By Product

8.1. Regenerative Medicine Market, by Product, 2016-2027
8.1.1. Needleless Systems
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Membrane-to-Membrane Systems
8.1.2.1. Market Revenue and Forecast (2016-2027)

Chapter 9. Global Regenerative Medicine Market, By Closing Mechanism

9.1. Regenerative Medicine Market, by Application, 2016-2027
9.1.1. Color-To-Color Alignment Systems
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Push-To-Turn Systems
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Click-To-Lock Systems
9.1.3.1. Market Revenue and Forecast (2016-2027)
9.1.4. Luer-Lock Systems
9.1.4.1. Market Revenue and Forecast (2016-2027)

Chapter 10. Global Regenerative Medicine Market, By Component

10.1. Regenerative Medicine Market, by Application, 2016-2027
10.1.1. Syringe Safety Devices
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Vial Access Devices
10.1.2.1. Market Revenue and Forecast (2016-2027)
10.1.3. Accessories
10.1.3.1. Market Revenue and Forecast (2016-2027)
10.1.4. Bag/Line Access Devices
10.1.4.1. Market Revenue and Forecast (2016-2027)

Chapter 11. Global Regenerative Medicine Market, By End User

11.1. Regenerative Medicine Market, by Application, 2016-2027
11.1.1. Clinics & Oncology Centers
11.1.1.1. Market Revenue and Forecast (2016-2027)
11.1.2. Hospitals
11.1.2.1. Market Revenue and Forecast (2016-2027)
11.1.3. Others
11.1.3.1. Market Revenue and Forecast (2016-2027)

Chapter 12. Global Regenerative Medicine Market, Regional Estimates and Trend Forecast

12.1. North America
12.1.1. Market Revenue Forecast by Type (2016-2027)
12.1.2. Market Revenue Forecast by Closing Mechanism (2016-2027)
12.1.3. Market Revenue Forecast by Component (2016-2027)
12.1.4. Market Revenue Forecast by End User (2016-2027)
12.1.5. U.S
12.1.5.1. Market Revenue Forecast (2016-2027)
12.1.6. Canada
12.1.6.1. Market Revenue Forecast (2016-2027)
12.2. Europe
12.2.1. Market Revenue Forecast by Type (2016-2027)
12.2.2. Market Revenue Forecast by Closing Mechanism (2016-2027)
12.2.3. Market Revenue Forecast by Component (2016-2027)
12.2.4. Market Revenue Forecast by End User (2016-2027)
12.2.5. UK
12.2.5.1. Market Revenue Forecast (2016-2027)
12.2.6. Germany
12.2.6.1. Market Revenue Forecast (2016-2027)
12.2.7. France
12.2.7.1. Market Revenue Forecast (2016-2027)
12.2.8. Rest of EU
12.2.8.1. Market Revenue Forecast (2016-2027)
12.3. Asia Pacific (APAC)
12.3.1. Market Revenue Forecast by Type (2016-2027)
12.3.2. Market Revenue Forecast by Closing Mechanism (2016-2027)
12.3.3. Market Revenue Forecast by Component (2016-2027)
12.3.4. Market Revenue Forecast by End User (2016-2027)
12.3.5. China
12.3.5.1. Market Revenue Forecast (2016-2027)
12.3.6. India
12.3.6.1. Market Revenue Forecast (2016-2027)
12.3.7. Japan
12.3.7.1. Market Revenue Forecast (2016-2027)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue Forecast (2016-2027)
12.4. LATAM
12.4.1. Market Revenue Forecast by Type (2016-2027)
12.4.2. Market Revenue Forecast by Closing Mechanism (2016-2027)
12.4.3. Market Revenue Forecast by Component (2016-2027)
12.4.4. Market Revenue Forecast by End User (2016-2027)
12.4.5. Brazil
12.4.5.1. Market Revenue Forecast (2016-2027)
12.4.6. Rest of LATAM
12.4.6.1. Market Revenue Forecast (2016-2027)
12.5. Middle East and Africa (MEA)
12.5.1. Market Revenue Forecast by Type (2016-2027)
12.5.2. Market Revenue Forecast by Closing Mechanism (2016-2027)
12.5.3. Market Revenue Forecast by Component (2016-2027)
12.5.4. Market Revenue Forecast by End User (2016-2027)
12.5.5. GCC
12.5.5.1. Market Revenue Forecast (2016-2027)
12.5.6. North Africa
12.5.6.1. Market Revenue Forecast (2016-2027)
12.5.7. South Africa
12.5.7.1. Market Revenue Forecast (2016-2027)
12.5.8. Rest of MEA
12.5.8.1. Market Revenue Forecast (2016-2027)

Chapter 13. Company Profiles

13.1. Baxter International Inc.
13.1.1. Company Overview, Business Information, Regional Presence
13.1.2. ProductPortfolio Analysis
13.1.2.1. ProductDetails, Specification, Application
13.1.3. Revenue, Price, and Gross Margin (2015-2020)
13.1.4. Recent Developments and Strategies
13.2. Becton, Dickinson, and Company
13.2.1. Company Overview, Business Information, Regional Presence
13.2.2. Product Portfolio Analysis
13.2.2.1. Product Details, Specification, Application
13.2.3. Revenue, Price, and Gross Margin (2015-2020)
13.2.4. Recent Developments and Strategies
13.3. CodanMedizinischeGeräte GmbH & Co Kg
13.3.1. Company Overview, Business Information, Regional Presence
13.3.2. Product Portfolio Analysis
13.3.2.1. Product Details, Specification, Application
13.3.3. Revenue, Price, and Gross Margin (2015-2020)
13.3.4. Recent Developments and Strategies
13.4. ICU Medical, Inc.
13.4.1. Company Overview, Business Information, Regional Presence
13.4.2. Product Portfolio Analysis
13.4.2.1. Product Details, Specification, Application
13.4.3. Revenue, Price, and Gross Margin (2015-2020)
13.4.4. Recent Developments and Strategies
13.5. Yukon Medical
13.5.1. Company Overview, Business Information, Regional Presence
13.5.2. Product Portfolio Analysis
13.5.2.1. Product Details, Specification, Application
13.5.3. Revenue, Price, and Gross Margin (2015-2020)
13.5.4. Recent Developments and Strategies
13.6. B. Braun Melsungen
13.6.1. Company Overview, Business Information, Regional Presence
13.6.2. Product Portfolio Analysis
13.6.2.1. Product Details, Specification, Application
13.6.3. Revenue, Price, and Gross Margin (2015-2020)
13.6.4. Recent Developments and Strategies
13.7. Equashield
13.7.1. Company Overview, Business Information, Regional Presence
13.7.2. Product Portfolio Analysis
13.7.2.1. Product Details, Specification, Application
13.7.3. Revenue, Price, and Gross Margin (2015-2020)
13.7.4. Recent Developments and Strategies
13.8. Teva Pharmaceutical Industries Ltd.
13.8.1. Company Overview, Business Information, Regional Presence
13.8.2. Product Portfolio Analysis
13.8.2.1. Product Details, Specification, Application
13.8.3. Revenue, Price, and Gross Margin (2015-2020)
13.8.4. Recent Developments and Strategies
13.9. Victus, Inc.
13.9.1. Company Overview, Business Information, Regional Presence
13.9.2. Product Portfolio Analysis
13.9.2.1. Product Details, Specification, Application
13.9.3. Revenue, Price, and Gross Margin (2015-2020)
13.9.4. Recent Developments and Strategies
13.10. Corvida Medical
13.10.1. Company Overview, Business Information, Regional Presence
13.10.2. Product Portfolio Analysis
13.10.2.1. Product Details, Specification, Application
13.10.3. Revenue, Price, and Gross Margin (2015-2020)
13.10.4. Recent Developments and Strategies